Australia - inglese - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone, quantity: 12 mg - tablet, modified release - excipient ingredients: polyethylene oxide; sodium chloride; povidone; stearic acid; butylated hydroxytoluene; iron oxide yellow; iron oxide red; hyetellose; macrogol 3350; cellulose acetate; hypromellose; titanium dioxide; macrogol 400; carnauba wax; iron oxide black; purified water; isopropyl alcohol; propylene glycol - invega is indicated for the treatment of schizophrenia, including acute treatment and recurrence prevention. invega is indicated for the treatment of acute exacerbations of schizoaffective disorder as monotherapy and in combination with antidepressants and/or mood stabilizers (lithium and valproate).

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - paliperidone - modified-release tablet - 3mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - paliperidone - modified-release tablet - 6mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - paliperidone - modified-release tablet - 9mg

Israele - inglese - Ministry of Health

j-c health care ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants

Israele - inglese - Ministry of Health

j-c health care ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants

Israele - inglese - Ministry of Health

j-c health care ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - paliperidone palmitate 156mg equivalent to paliperidone 100mg - suspension for injection - 100 mg - active: paliperidone palmitate 156mg equivalent to paliperidone 100mg excipient: citric acid monohydrate dibasic sodium phosphate dibasic sodium phosphate monohydrate macrogols polysorbate 20 sodium hydroxide water for injection - indicated for the acute and maintenance treatment of schizophrenia in adults.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - paliperidone palmitate 234mg equivalent to paliperidone 150mg - suspension for injection - 150 mg - active: paliperidone palmitate 234mg equivalent to paliperidone 150mg excipient: citric acid monohydrate dibasic sodium phosphate dibasic sodium phosphate monohydrate macrogols polysorbate 20 sodium hydroxide water for injection - indicated for the acute and maintenance treatment of schizophrenia in adults.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - paliperidone palmitate 39mg equivalent to paliperidone 25mg - suspension for injection - 25 mg - active: paliperidone palmitate 39mg equivalent to paliperidone 25mg excipient: citric acid monohydrate dibasic sodium phosphate dibasic sodium phosphate monohydrate macrogols polysorbate 20 sodium hydroxide water for injection - indicated for the acute and maintenance treatment of schizophrenia in adults.